
Health
26 January 2021, 2:46 pm. 1 minute
Reuters exclusively reported that AstraZeneca has offered to bring forward some deliveries of its COVID-19 vaccine to the European Union, while the bloc has asked the British drugmaker if it can divert doses from the UK to make up for a shortfall in supplies. Reuters revealed on Friday that AstraZeneca would cut supplies to the EU of its vaccine candidate in the first quarter of this year, a move that a senior EU official told Reuters meant a 60% reduction to 31 million doses for the bloc. That complicated the EU’s vaccination plans, after Pfizer had also announced a temporary slowdown in deliveries of its vaccine, and triggered an outcry in Brussels and EU capitals.
Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Equities
Regions: Europe
Countries: Belgium
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
More Stories
Reuters exclusively reports Germany wants to buy Sputnik COVID vaccine if approved by EU
Reuters exclusively reports EU blocks 3.1 million doses of AstraZeneca shots to Australia
Reuters exclusively reports Fauci says U.S. may not need AstraZeneca COVID-19 vaccine